KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Deffered Revenue (2016 - 2019)

Bristol Myers Squibb has reported Non-Current Deffered Revenue over the past 11 years, most recently at $448.0 million for Q1 2019.

  • Quarterly Non-Current Deffered Revenue changed 0.22% to $448.0 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $448.0 million through Mar 2019, changed 0.22% year-over-year, with the annual reading at $468.0 million for FY2018, 3.08% up from the prior year.
  • Non-Current Deffered Revenue was $448.0 million for Q1 2019 at Bristol Myers Squibb, down from $468.0 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $697.0 million in Q1 2015 and troughed at $447.0 million in Q1 2018.
  • The 5-year median for Non-Current Deffered Revenue is $528.0 million (2017), against an average of $542.5 million.
  • Year-over-year, Non-Current Deffered Revenue tumbled 35.99% in 2015 and then rose 3.08% in 2018.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $586.0 million in 2015, then decreased by 6.66% to $547.0 million in 2016, then dropped by 17.0% to $454.0 million in 2017, then rose by 3.08% to $468.0 million in 2018, then dropped by 4.27% to $448.0 million in 2019.
  • Per Business Quant, the three most recent readings for BMY's Non-Current Deffered Revenue are $448.0 million (Q1 2019), $468.0 million (Q4 2018), and $486.0 million (Q3 2018).